Arbutus Biopharma Corp (ABUS)
3.51
+0.05
(+1.45%)
USD |
NASDAQ |
Nov 22, 16:00
3.51
0.00 (0.00%)
After-Hours: 20:00
Arbutus Biopharma Stock Buybacks (Quarterly): 0.00 for Sept. 30, 2024
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 0.00 |
June 30, 2024 | -22.36M |
March 31, 2024 | -21.76M |
December 31, 2023 | -3.852M |
September 30, 2023 | -1.396M |
June 30, 2023 | -4.742M |
March 31, 2023 | -19.86M |
December 31, 2022 | -11.08M |
September 30, 2022 | -8.973M |
June 30, 2022 | 0.00 |
March 31, 2022 | -0.268M |
December 31, 2021 | -59.24M |
September 30, 2021 | -44.74M |
June 30, 2021 | -4.274M |
March 31, 2021 | -26.42M |
December 31, 2020 | -20.18M |
September 30, 2020 | -48.76M |
June 30, 2020 | -5.045M |
March 31, 2020 | -12.32M |
December 31, 2019 | -13.88M |
September 30, 2019 | 0.00 |
June 30, 2019 | -2.477M |
March 31, 2019 | -2.248M |
December 31, 2018 | 0.00 |
September 30, 2018 | 0.00 |
Date | Value |
---|---|
June 30, 2018 | 0.00 |
March 31, 2018 | |
December 31, 2017 | |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | 0.00 |
September 30, 2016 | |
June 30, 2016 | 0.00 |
March 31, 2016 | |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.00 |
June 30, 2015 | -0.002M |
March 31, 2015 | -142.18M |
December 31, 2014 | 0.00 |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.00 |
March 31, 2014 | -56.48M |
December 31, 2013 | -32.04M |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.059M |
September 30, 2012 | -0.1261M |
June 30, 2012 | 0.0734M |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-59.24M
Minimum
Dec 2021
--
Maximum
Jun 2022
-16.46M
Average
-11.70M
Median
Stock Buybacks (Quarterly) Benchmarks
Biomarin Pharmaceutical Inc | -- |
Amicus Therapeutics Inc | -19.15M |
Ionis Pharmaceuticals Inc | -496.10M |
GlycoMimetics Inc | 0.00 |
FibroGen Inc | 0.00 |